SCHEMBL17345

SCHEMBL17345

CCCC1C(=O)NCCN1C[C@H]1CN(S(=O)(=O)c2cccs2)CCN1c1ccc(C(C)(O)C(F)(F)F)cc1

nearest known ligand 0.64

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 12/20 0.64
GCKR Q14397 8/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16842 0.90 GCK (0.70) GCKGCKR
SCHEMBL12078155 0.90 GCK (0.70) GCKGCKR
SCHEMBL19980 0.90 GCK (0.70) GCKGCKR
SCHEMBL18957 0.88 GCK (0.66) GCKGCKR
SCHEMBL18520 0.88 GCK (0.66) GCKGCKR
SCHEMBL18645 0.88 GCK (0.66) GCKGCKR
SCHEMBL18649 0.88 GCK (0.66) GCKGCKR
SCHEMBL12079065 0.88 GCK (0.66) GCKGCKR
SCHEMBL17343 0.88 GCK (0.66) GCKGCKR
SCHEMBL12079662 0.88 GCK (0.66) GCKGCKR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed